160 related articles for article (PubMed ID: 11216919)
1. Chemotherapy for malignant brain tumors of astrocytic and oligodendroglial lineage.
Hofer S; Herrmann R
J Cancer Res Clin Oncol; 2001 Feb; 127(2):91-5. PubMed ID: 11216919
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading.
Levin VA
Neuro Oncol; 1999 Jan; 1(1):69-80. PubMed ID: 11550304
[TBL] [Abstract][Full Text] [Related]
3. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
[TBL] [Abstract][Full Text] [Related]
4. PCV for oligodendroglial tumors: in search of prognostic factors for response and survival.
Fortin D; Macdonald DR; Stitt L; Cairncross JG
Can J Neurol Sci; 2001 Aug; 28(3):215-23. PubMed ID: 11513339
[TBL] [Abstract][Full Text] [Related]
5. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine.
Webre C; Shonka N; Smith L; Liu D; De Groot J
Anticancer Res; 2015 Oct; 35(10):5467-72. PubMed ID: 26408710
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
[TBL] [Abstract][Full Text] [Related]
7. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.
Glass J; Hochberg FH; Gruber ML; Louis DN; Smith D; Rattner B
J Neurosurg; 1992 May; 76(5):741-5. PubMed ID: 1564535
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for low-grade gliomas.
Mason WP
Forum (Genova); 2000; 10(2):95-104. PubMed ID: 10875972
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942
[TBL] [Abstract][Full Text] [Related]
10. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
Finlay JL; Boyett JM; Yates AJ; Wisoff JH; Milstein JM; Geyer JR; Bertolone SJ; McGuire P; Cherlow JM; Tefft M
J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011
[TBL] [Abstract][Full Text] [Related]
11. Multimodality management of recurrent adult malignant gliomas: results of a phase II multiagent chemotherapy study and analysis of cytoreductive surgery.
Rostomily RC; Spence AM; Duong D; McCormick K; Bland M; Berger MS
Neurosurgery; 1994 Sep; 35(3):378-88; discussion 388. PubMed ID: 7800129
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for high-grade gliomas.
Galanis E; Buckner J
Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
[No Abstract] [Full Text] [Related]
13. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
[TBL] [Abstract][Full Text] [Related]
14. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
[TBL] [Abstract][Full Text] [Related]
15. [Evolution of chemotherapy for malignant brain tumors].
Takeshima H; Kuratsu J
No Shinkei Geka; 2003 Jul; 31(7):725-34. PubMed ID: 12884787
[No Abstract] [Full Text] [Related]
16. Clinicopathological study of oligodendroglial tumors: the effectiveness of interferon beta, ACNU/MCNU, and radiation (IAR/IMR) for anaplastic tumors.
Wakabayashi T; Kajita Y; Hatano N; Thompson T; Nagasaka T; Yoshida J
Brain Tumor Pathol; 2000; 17(1):29-33. PubMed ID: 10982007
[TBL] [Abstract][Full Text] [Related]
17. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
[TBL] [Abstract][Full Text] [Related]
18. Ras pathway activation in gliomas: a strategic target for intranasal administration of perillyl alcohol.
da Fonseca CO; Linden R; Futuro D; Gattass CR; Quirico-Santos T
Arch Immunol Ther Exp (Warsz); 2008; 56(4):267-76. PubMed ID: 18726148
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prognostic factors in chemotherapy of recurrent brain tumors.
Eagan RT; Scott M
J Clin Oncol; 1983 Jan; 1(1):38-44. PubMed ID: 6321671
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy of oligodendroglial tumours: current developments.
van den Bent MJ
Forum (Genova); 2000; 10(2):108-18. PubMed ID: 10875973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
